INDmoney
Bioxcel Therapeutics Stock Performance
as on February 14, 2026 at 7:59 am IST
Day's Low
Day's High
$1.54$1.60
2.53%
Downside
1.27%
Upside
52 Week's Low
52 Week's High
$1.17$8.0825.95%
Downside
411.39%
Upside
Bioxcel Therapeutics share price movements today
- Previous Close
- $1.54
- Open
- $1.54
- Volume
- 518.4K
- Day's Low - High
- $1.54 - $1.60
- 52 Week Low - High
- $1.17 - $8.08
Bioxcel Therapeutics Historical Returns
- 1 Month Return
- -14.13 %
- 3 Month Return
- -3.07 %
- 1 Year Return
- -31.6 %
- 3 Year Return
- -99.7 %
- 5 Year Return
- -99.83 %
Bioxcel Therapeutics Stock Fundamentals & Key Indicators
Check Bioxcel Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$34.6M
EPS (TTM)
-6.7
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-0.24
Industry PE ratio
-3.5951014492753623
PEG Ratio
0EBITDA
-50.1M
Revenue (TTM)
752.0K
Profit Margin
0.00%
Return On Equity TTM
-1766.94%
Bioxcel Therapeutics Stock Valuation
Track how Bioxcel Therapeutics P/E has moved over time to understand its valuation trends.
Bioxcel Therapeutics in the last 5 years
Lowest (-197.17x)
March 31, 2021
Industry (-3.60x)
February 16, 2026
Today (-0.24x)
February 16, 2026
Highest (-0.21x)
June 30, 2025
Today’s Price to Earnings Ratio: -0.24x
Bioxcel Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Bioxcel Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $34.6M | -99.83% | -0.24 | 0.00% | |
| NA | $15.4B | NA | NA | 0.00% | |
| BUY | $21.4B | NA | 17.96 | 40.65% | |
| BUY | $49.9B | NA | 24.89 | 13.81% | |
| HOLD | $18.2B | -13.99% | -21.95 | -26.13% |
Stock Returns calculator for Bioxcel Therapeutics Stock including INR - Dollar returns
The Bioxcel Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Bioxcel Therapeutics investment value today
Current value as on today
₹72,778
Returns
Returns from Bioxcel Therapeutics Stock
Dollar Returns*
₹4,380 (+4.38%)
Analyst Recommendation on Bioxcel Therapeutics Stock
Based on 13 analysts
69.23%
Buy
30.77%
Hold
0.00%
Sell
Based on 13 analysts, 69.23% of analysts recommend a 'BUY' rating for Bioxcel Therapeutics. Average target price of $15.25
Bioxcel Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Bioxcel Therapeutics.
What analysts predicted
89.64%UPSIDE
Target Price
$15.25
Current Price
$1.58
Analyzed by
13 Analysts
Target
$15.25
Bioxcel Therapeutics target price $15.25, a slight upside of 89.64% compared to current price of $1.58. According to 13 analysts rating.
Bioxcel Therapeutics Stock’s Investor Sentiment and Interest
Search interest for Bioxcel Therapeutics Stock has decreased by -5% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Bioxcel Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Bioxcel Therapeutics Annual Profit & Loss
All numbers in Millions USD
Bioxcel Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Bioxcel Therapeutics Annual Cash Flow
All numbers in Millions USD
Insights on Bioxcel Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Regencell Bioscience Holdings Ltd has given 31531.2% return, outperforming this stock by 31562.8%
- NO EFFECT
Against Peers
In the last 3 years, Regencell Bioscience Holdings Ltd has given 4286.1% return, outperforming this stock by 4385.8%
NEGATIVE IMPACTPrice Dip
In the last 6 months, BTAI stock has moved down by -71.2%
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 4 quarters, 366.0K → 98.0K (in $), with an average decrease of 33.7% per quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, -7.25M → -30.91M (in $), with an average decrease of 112.8% per quarter
About Bioxcel Therapeutics
| Organisation | Bioxcel Therapeutics |
| Headquarters | 555 Long Wharf Drive, New Haven, CT, United States, 06511 |
| Industry | Health Technology |
| CEO | Dr. Vimal D. Mehta Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Bioxcel Therapeutics
Name | Title |
|---|---|
Mr. Mark Pavao | Acting Chief Commercial Officer |
Mr. Matt Mandel | Vice President of Clinical Development |
Dr. Vimal D. Mehta Ph.D. | Founder, CEO, President, & Director |
Mr. Richard I. Steinhart MBA | Senior VP & CFO |
Mr. Javier Rodriguez J.D. | Senior VP, Chief Legal Officer & Corporate Secretary |
Dr. Frank D. Yocca Ph.D. | Executive VP & Chief Scientific Officer |
FAQs
What is Bioxcel Therapeutics share price today?
Bioxcel Therapeutics share price today is $1.58 as on at the close of the market. Bioxcel Therapeutics share today touched a day high of $1.6 and a low of $1.54.
What is the 52 week high and 52 week low for Bioxcel Therapeutics share?
Bioxcel Therapeutics share touched a 52 week high of $8.08 on and a 52 week low of $1.17 on . Bioxcel Therapeutics stock price today i.e. is closed at $1.58,which is 80.45% down from its 52 week high and 35.04% up from its 52 week low.
What is Bioxcel Therapeutics's market capitalisation today?
Bioxcel Therapeutics market capitalisation is $0.00T as on .
How to invest in Bioxcel Therapeutics Stock (BTAI) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Bioxcel Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bioxcel Therapeutics Shares that will get you 0.9494 shares as per Bioxcel Therapeutics share price of $1.58 per share as on February 14, 2026 at 2:29 am IST.
What is the minimum amount required to buy Bioxcel Therapeutics Stock (BTAI) from India?
Indian investors can start investing in Bioxcel Therapeutics (BTAI) shares with as little as ₹90.64 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹906.40 in Bioxcel Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Bioxcel Therapeutics share’s latest price of $1.58 as on February 14, 2026 at 2:29 am IST, you will get 6.3291 shares of Bioxcel Therapeutics. Learn more about
fractional shares .
What are the returns that Bioxcel Therapeutics has given to Indian investors in the last 5 years?
Bioxcel Therapeutics stock has given -99.83% share price returns and 24.7% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?